| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
| Recent developments in the biotechnology sector highlight significant advancements, particularly in cancer therapies and collaborations, such as C4 Therapeutics working with Roche. The integration of AI in drug discovery is also emerging as a promising trend, potentially enhancing innovation and efficiency. However, the sector faces regulatory challenges that can impact stock performance, as seen with Replimune. Overall, the biotechnology landscape is characterized by potential growth coupled with inherent risks and market fluctuations. The price action of Biotechnology (IBB) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The trend sentiment at 1.1 is very bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.IBB is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for Biotechnology sector is at 1, and the negative at -0.1 on 2026-04-15. The forces of Market Risk Appetite (2), Broad Market Trend (1.6), Sector Price Trend (1.1), Sentiment towards Fundamentals (1.1), Option Sentiment (0.1), and Valuation Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (-0.5) will drive down the price. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on IBB trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice Sector Rotation Notification
| IBB | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | 0%(0%) | 175.99 | 2.63% | 96 | 0.08% | 0.41% | 1.1 | 0.3 | 0.7% | 0.9 | Wait | 50% | 1.1 | 7.5 |
| 2026-04-14 | 0%(0%) | 175.85 | 2.39% | 102 | 2.13% | 0.83% | 1.9 | 0.5 | 1.4% | 1.3 | Long | 70% | 2 | 4.8 |
| 2026-04-13 | 0%(0%) | 172.19 | 2.14% | 87 | 1.66% | 0.71% | 1.3 | 0.4 | 0.7% | 1.3 | Long | 55% | 2.1 | 6 |
| 2026-04-12 | 0%(0%) | 0.2 | 1.4 | 2.2 | -0.5 | |||||||||
| 2026-04-11 | 0%(0%) | 0.2 | 1.3 | 2.1 | -0.5 | |||||||||
| 2026-04-10 | 0%(0%) | 169.37 | 2.05% | 72 | -1.62% | 0.24% | 0.2 | 0 | 0% | 1.7 | Long | 55% | 2.8 | -8.5 |
| 2026-04-09 | 0%(0%) | 172.16 | 1.97% | 94 | 0.17% | 0.36% | 0.7 | 0 | 0% | 1.5 | Long | 55% | 3.1 | 6.2 |
| 2026-04-08 | 0%(0%) | 171.86 | 1.91% | 94 | 1.99% | 0.6% | 1 | 0 | 0% | 1.6 | Long | 55% | 3.4 | 6.5 |
| 2026-04-07 | 0%(0%) | 168.5 | 1.98% | 68 | -0.2% | 0.36% | 1.1 | 0 | 0% | 1 | Long | 55% | 1.9 | 6.8 |
| 2026-04-06 | 0%(0.1%) | 168.83 | 2.06% | 68 | -0.35% | 0.42% | 1.5 | 0 | 0% | 1.2 | Long | 65% | 1.8 | 7.5 |
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Rules, Risk & Reward: How Regulation Is Shaping Biotech (IBB) Sun. Oct 5, 2025 | ||
| ● A Summary of Recent Product/Service Development in Biotech Sector Sun. Oct 5, 2025 | ||
| ● Biotech Earnings Check-In: Where Strength Is Building (and Where It Isn’t) Sun. Oct 5, 2025 | ||
| Market News | ||
| 1 (8) Israeli start-up makes world’s first lab-grown chocolate bar Mondelez-backed Celleste Bio says its ‘cell-cultured’ cocoa butter is identical to traditional product (https://www.ft.com/) Wed. Apr 15, 2026 | ||
| 2 (4) This biotech firm has room to run, even as its drug royalties are set to shrink Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will support its growth, per Piper Sandler. (https://www.cnbc.com/) Tue. Apr 14, 2026 | ||
| 3 (2) Could AbbVie Crash Lilly's Weight‑Loss Party? AbbVie is making progress in this market, but it is still far behind the leader. (https://www.fool.com/) Tue. Apr 14, 2026 | ||
| 4 (7) Anthropic adds Novartis CEO Vas Narasimhan to its board Anthropic on Tuesday added Novartis' Chief Executive Officer Vas Narasimhan to its board of directors, making him the first executive from the pharmaceutical industry to join the AI startup's governing body. * Narasimhan joins Anthropic CEO Dario Amodei, PresidentDaniela Amodei, Confluent CEO Jay Kreps, Netflix chairman ReedHastings, and others on the board. * This marks the second new board addition after the Claudechatbot developer added Chris Liddell, a former Microsoftexecutive to its board in February. (https://finance.yahoo.com/) Tue. Apr 14, 2026 | ||
| 5 (8) Novo Nordisk partners with OpenAI as AI drug discovery hopes mount The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs. (https://www.cnbc.com/) Tue. Apr 14, 2026 | ||
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA